Kristen Carlson

Mr. Kristen Carlson

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Neuromodulation: Technology at the Neural Interface
Verified
Journal Article
Closed access
PDF file
JAJeffrey E. Arle
Jeffrey E. Arle
LMLongzhi Mei
Longzhi Mei
KCKristen Carlson
Kristen Carlson
JSJay L. Shils
Jay L. Shils

10 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
AAAlondra Aguilar
Alondra Aguilar
Michelle HoMichelle Ho
Michelle Ho
ECEdwin Chang
Edwin Chang
KCKristen Carlson
Kristen Carlson
ANArutselvan Natarajan
Arutselvan Natarajan
CPChirag Patel
Chirag Patel
The biological impact of exogenous, alternating electric fields (AEFs) and direct-current electric fields has a long history of study, ranging from effects on embryonic development to influences on wound healing. In this article, we focus on the application of electric fields for the treatment of cancers. In particular, we outline the clinical impact of tumor treating fields (TTFields), a form of AEFs, on the treatment of cancers such as glioblastoma and mesothelioma. We provide an overview of the standard mechanism of action of TTFields, namely, the capability for AEFs (e.g., TTFields) to disrupt the formation and segregation of the mitotic spindle in actively dividing cells. Though this standard mechanism explains a large part of TTFields’ action, it is by no means complete. The standard theory does not account for exogenously applied AEFs’ influence directly upon DNA nor upon their capacity to alter the functionality and permeability of cancer cell membranes. This review summarizes the current literature to provide a more comprehensive understanding of AEFs’ actions on cell membranes. It gives an overview of three mechanistic models that may explain the more recent observations into AEFs’ effects: the voltage-gated ion channel, bioelectrorheological, and electroporation models. Inconsistencies were noted in both effective frequency range and field strength between TTFields versus all three proposed models. We addressed these discrepancies through theoretical investigations into the inhomogeneities of electric fields on cellular membranes as a function of disease state, external microenvironment, and tissue or cellular organization. Lastly, future experimental strategies to validate these findings are outlined. Clinical benefits are inevitably forthcoming.

1 October 2016 in Epilepsy Research
Verified
Journal Article
Closed access
JAJeffrey E. Arle
Jeffrey E. Arle
KCKristen Carlson
Kristen Carlson
LMLongzhi Mei
Longzhi Mei

Verified
Journal Article
Open access
PDF file
KCKristen Carlson
Kristen Carlson
Artificial general intelligence (AGI) progression metrics indicate AGI will occur within decades. No proof exists that AGI will benefit humans and not harm or eliminate humans. A set of logically distinct conceptual components is proposed that are necessary and sufficient to (1) ensure various AGI scenarios will not harm humanity, and (2) robustly align AGI and human values and goals. By systematically addressing pathways to malevolent AI we can induce the methods/axioms required to redress them. Distributed ledger technology (DLT, “blockchain”) is integral to this proposal, e.g., “smart contracts” are necessary to address the evolution of AI that will be too fast for human monitoring and intervention. The proposed axioms: (1) Access to technology by market license. (2) Transparent ethics embodied in DLT. (3) Morality encrypted via DLT. (4) Behavior control structure with values at roots. (5) Individual bar-code identification of critical components. (6) Configuration Item (from business continuity/disaster recovery planning). (7) Identity verification secured via DLT. (8) “Smart” automated contracts based on DLT. (9) Decentralized applications—AI software modules encrypted via DLT. (10) Audit trail of component usage stored via DLT. (11) Social ostracism (denial of resources) augmented by DLT petitions. (12) Game theory and mechanism design.

1 July 2020 in Neuromodulation: Technology at the Neural Interface
Verified
Journal Article
Closed access
JAJeffrey E. Arle
Jeffrey E. Arle
LMLongzhi Mei
Longzhi Mei
KCKristen Carlson
Kristen Carlson

29 May 2025 in SuperIntelligence - Robotics - Safety & Alignment
Verified
Journal Article
Open access
PDF file
KCKristen Carlson
Kristen Carlson
We evaluated 4 systems (ELIZA, GPT-4o, LLaMa-3.1-405B, and GPT-4.5) in two randomised, controlled, and pre-registered Turing tests on independent populations. Participants had 5 minute conversations simultaneously with another human participant and one of these systems before judging which conversational partner they thought was human. When prompted to adopt a humanlike persona, GPT-4.5 was judged to be the human 73% of the time: significantly more often than interrogators selected the real human participant. LLaMa-3.1, with the same prompt, was judged to be the human 56% of the time—not significantly more or less often than the humans they were being compared to—while baseline models (ELIZA and GPT-4o) achieved win rates significantly below chance (23% and 21% respectively). The results constitute the first empirical evidence that any artificial system passes a standard three-party Turing test. The results have implications for debates about what kind of intelligence is exhibited by Large Language Models (LLMs), and the social and economic impacts these systems are likely to have.